Cullman Clinical Trials | Cullman, AL logo

Cullman Clinical Trials | Cullman, AL

Research site
Location
501 Clark Street North East, Cullman, Alabama, United States of America

Site insights

Top conditions

Top treatments

Bimagrumab
Cenicriviroc
Naltrexone Hydrochloride
Bupropion Hydrochloride
AZD7442
AXA1125
Semaglutide
Zotatifin
SNG001
LY3437943

Data sourced from clinicaltrials.gov

Active trials

9 of 26 total trials

A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

The purpose of this study is to evaluate the immunogenicity, safety, and reactogenicity of mRNA-1083 as compared with active control, co-administered...

Active, not recruiting
Influenza
SARS-CoV-2
Biological: COVID-19 Vaccine
Biological: mRNA-1083

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

The purpose of this study is to learn about the safety and effects of sisunatovir. Sisunatovir is studied for the possible treatment of Respiratory S...

Enrolling
Respiratory Syncytial Virus Infection
Drug: Sisunatovir
Drug: Placebo

The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 recep...

Enrolling
Obesity
Muscle Loss
Drug: Semaglutide
Drug: Enobosarm

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination

This is a clinical trial to evaluate the safety, PK, viral shedding and clinical effects of Pentarlandir™ UPPTA in patients with early COVID-19. Appr...

Enrolling
Coronavirus Disease 2019
Drug: Pentarlandir™ UPPTA
Drug: Placebo

A phase 2 study to assess the efficacy of bimagrumab alone or in addition to semaglutide to assess efficacy and safety in overweight or obese men and...

Active, not recruiting
Overweight or Obesity
Obese
Other: Bimagrumab Placebo
Biological: Bimagrumab

This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (stea...

Enrolling
Non Alcoholic Steatohepatitis (NASH)
Drug: AXA1125
Drug: Placebo

This Phase 2, randomized, observer-blind clinical study is evaluating 3 different priming and booster regimens with MF59-adjuvanted H5N8 and/or H5N6...

Active, not recruiting
Influenza, Human
Infection Viral
Biological: aH5N6c on Day 1
Biological: aH5N8c on Day 202

Trial sponsors

Exact Sciences Corporation logo
Lilly logo
L
Pfizer logo
A
Bristol-Myers Squibb (BMS) logo
C
D
Effector Therapeutics logo
Genentech logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems